Study proves Pfizer vaccine can neutralize UK, South Africa virus variants

▴ Study proves Pfizer vaccine can neutralize UK, South Africa virus variants
Pfizer vaccine update

 The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.

According to the scientists, including those from the University of Texas in the US, these variants have a substitution of the amino acid building blocks that make up the viral spike protein — the part of the virus which enables it to enter human cells.

They said these mutations in the 501st and 484th positions of the protein’s amino acid molecule chain appeared in the UK and the South African variants, and could potentially increase the affinity of the viral spike for the receptor on the human cell through which the virus enters cells.

In particular, they said the N501Y mutation may also expand the range of hosts the virus can infect to include mice.

In the current study, the scientists, Pei-Yong Shi and his colleagues engineered combinations of mutations found in these circulating variants and tested a panel of human sera from 20 participants.

They said the sera were obtained from their clinical trial of the Pfizer-BioNtech vaccine obtained two or four weeks after immunisation with two doses spaced three weeks apart.

When they tested the serum against the coronavirus strains, the authors found evidence of neutralisation of the mutant viruses by the sera panel, with slight variation. According to the scientists, neutralisation against the E484K mutation was slightly lower than that against the N501Y mutation.

Commenting on the research, virologist Lawrence Young from the University of Warwick in the UK, said the findings confirm previous studies indicating that the Pfizer vaccine is very likely to be effective against the UK variant.

Story Source

PTI

Tags : #Pfizer #PfizerVaccine #BioNTech #BioNTechVaccine #UKVariantCovid #SouthAfricaVariantCovid #UniversityofWarwick

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Is Your Cooking Oil Poisoning You? The Truth About Seed OilsMarch 11, 2025
Think Before You Bite: How Fatty Foods Can Trigger Brain Damage in Just 3 DaysMarch 11, 2025
Ditch the Pills: The Secret to Beating Insomnia is in Your WorkoutMarch 11, 2025
The University of Tasmania invites applications for Master of Public HealthMarch 11, 2025
CBM India Celebrates International Women's Day with Free Eye Screening in HyderabadMarch 11, 2025
Is patriarchy petrifying governments to deliver on gender equality?March 11, 2025
Change happens when gender inequality survivors join hands to stop TB March 10, 2025
Arogya World Hosts #RunInRed With 1500+ Bengalureans To Raise Awareness on Women’s Heart HealthMarch 10, 2025
Sharda Group Launches Sharda Care - Healthcity, a State-of-the-Art Facility with Smart Infrastructure in Greater NoidaMarch 10, 2025
Can Just Three Days of Junk Food Harm Your Brain? Science Says YesMarch 08, 2025
Your Night Shifts Might Be Damaging Your DNA: Here’s How to Fight BackMarch 08, 2025
India’s Women: Empowered on Paper, Struggling in RealityMarch 08, 2025
NephroPlus to Launch Nationwide Free Health Screening Campaign to Commemorate World Kidney Day 2025 March 07, 2025
Skinny But Sick? Is our Body Mass Index Misleading UsMarch 07, 2025
Scientists Stumble Upon a Cancer-Fighting Secret Hidden in Your Medicine CabinetMarch 07, 2025
The Bitter Truth About Butter: Is our Favourite Spread Cutting our Life Short?March 07, 2025
March 07, 2025
March 06, 2025
University of Leeds scientists offer hope for people facing chronic painMarch 06, 2025
Impact of excessive use of gym supplements on gym enthusiastsMarch 06, 2025